We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$207M
AUM Growth
+$72.1M
Cap. Flow
+$59.3M
Cap. Flow %
28.65%
Top 10 Hldgs %
47.42%
Holding
159
New
12
Increased
64
Reduced
2
Closed
5

Sector Composition

Rank Sector Weight
1 Energy 63.86%
2 Healthcare 21.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDX icon
126
Celldex Therapeutics
CLDX
$2.77B
$241K 0.12%
3,969
OMED
127
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$232K 0.11%
20,269
NS
128
DELISTED
NuStar Energy L.P.
NS
$228K 0.11%
4,608
+1,551
+51% +$74.7K
TCRT icon
129
Alaunos Therapeutics
TCRT
$4.74M
$226K 0.11%
268
INO icon
130
Inovio Pharmaceuticals
INO
$79.8M
$224K 0.11%
2,005
PTLA
131
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$221K 0.11%
9,735
ACHN
132
DELISTED
Achillion Pharmaceuticals
ACHN
$218K 0.11%
26,915
ISEE
133
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$217K 0.1%
4,702
ESPR
134
DELISTED
Esperion Therapeutics
ESPR
$215K 0.1%
15,540
EPZM
135
DELISTED
Epizyme, Inc
EPZM
$214K 0.1%
21,750
CNCE
136
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$212K 0.1%
20,939
GERN icon
137
Geron
GERN
$911M
$208K 0.1%
91,851
QURE icon
138
uniQure
QURE
$2.68B
$203K 0.1%
26,511
SGMO
139
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$191K 0.09%
41,249
ADAP
140
DELISTED
Adaptimmune Therapeutics
ADAP
$190K 0.09%
26,974
IMGN
141
DELISTED
Immunogen Inc
IMGN
$190K 0.09%
70,796
OKE icon
142
Oneok
OKE
$58.7B
$185K 0.09%
3,591
+1,213
+51% +$57.4K
SEP
143
DELISTED
Spectra Engy Parters Lp
SEP
$184K 0.09%
4,205
+1,417
+51% +$65.4K
DVAX
144
DELISTED
Dynavax Technologies
DVAX
$181K 0.09%
17,302
JUNO
145
DELISTED
Juno Therapeutics, Inc.
JUNO
$181K 0.09%
6,017
IYF icon
146
iShares US Financials ETF
IYF
$4.39B
$179K 0.09%
+3,972
New +$178K
AGTC
147
DELISTED
Applied Genetic Technologies Corporation
AGTC
$159K 0.08%
16,223
IDU icon
148
iShares US Utilities ETF
IDU
$1.41B
$154K 0.07%
+2,508
New +$159K
RGLS
149
DELISTED
Regulus Therapeutics
RGLS
$153K 0.07%
386
MCRB icon
150
Seres Therapeutics
MCRB
$48M
$100K 0.05%
405

Similar funds

Virtus ETF Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, Virtus ETF Advisers held 159 positions worth $207M, up 53% from $135M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Virtus ETF Advisers deployed $59.3M of net new capital in Q3 2016, opening 12 new positions and adding to 64 existing holdings. Its largest new stake was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, down from 64% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Williams Companies, an estimated $4.42M trimmed.

  • Virtus ETF Advisers's largest Q3 2016 buy was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.
  • Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q3 2016, an estimated $6.79M increase.
  • Virtus ETF Advisers's biggest Q3 2016 reduction was Williams Companies, cutting an estimated $4.42M.
  • Virtus ETF Advisers fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $546K.
  • Virtus ETF Advisers's ten largest holdings make up 47% of its $207M portfolio in Q3 2016.
  • Virtus ETF Advisers opened 12 new positions and closed 5 in Q3 2016.
  • Virtus ETF Advisers's portfolio value rose 53% quarter-over-quarter to $207M.

Based on Virtus ETF Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.